Status
Conditions
Study type
Funder types
Identifiers
About
The study of plasma and urine proteomic profiles in patients with ischemic brain injury is important to better understanding of the mechanisms by which thrombolytic agents or other therapy affects clinical outcomes. The purpose of this study is to study the proteomic profile of patients with ischemic brain injury and compare it to control subjects without ischemic brain injury, subjects with other chronic neurologic diseases or systemic vascular diseases, and pre- and post- therapy which may be associated with, or predictive of, therapeutic outcome.
The investigators hypothesize that there is a unique set of proteins expressed in serum and urine in patients with ischemic brain injury that may provide a more complete understanding of ischemic brain injury pathophysiology.
Ultimately, this study may provide information of direct relevance to the medical care of a large proportion of patients with ischemic brain injury and other neurologic diseases in the future. And proteomic proteomic profile may provide important information about the roles of specific biomarkers. Perhaps the prevention of ischemic injury related complications.
Enrollment
Sex
Volunteers
Inclusion and exclusion criteria
Case Inclusion and Exclusion Criteria:
Inclusion Criteria:
Exclusion Criteria:
Controls Inclusion and Exclusion Criteria:
Inclusion Criteria:
Exclusion Criteria:
Loading...
Central trial contact
MingMing Ning, M.D. (PI)
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal